Institutional Ownership Nuvectis Pharma, Inc. (NVCT)
This table provides information about the institutional ownership of Nuvectis Pharma, Inc. (NVCT). We have compiled data on the 40 institutions that hold shares in the stock, with a total of 1.83 Million shares, which have been reported (via 13F filing form) to have a value of $14.3 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Ronit Capital LLP
|
Nov 04, 2022 Q3 2022 |
562,547
shares
|
$4.11 Million
5.37% of portfolio
|
Q3 2022
Added 34.17%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 13, 2024 Q2 2024 |
251,138
shares
|
$1.83 Million
0.0% of portfolio
|
Q2 2024
Reduced 15.95%
|
|
Baldwin Brothers LLC
|
Oct 15, 2024 Q3 2024 |
174,130
shares
|
$1.27 Million
0.08% of portfolio
|
Q3 2024
Added 3.26%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2024 Q2 2024 |
119,459
shares
|
$872,050
0.0% of portfolio
|
Q2 2024
Added 202.42%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
83,412
shares
|
$608,907
0.0% of portfolio
|
Q2 2024
Reduced 77.62%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 09, 2024 Q2 2024 |
74,500
shares
|
$543,850
0.0% of portfolio
|
Q2 2024
Added 20.75%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 13, 2024 Q2 2024 |
61,570
shares
|
$449,461
0.0% of portfolio
|
Q2 2024
New holding
|
|
Iridian Asset Management LLC
|
Oct 25, 2024 Q3 2024 |
55,380
shares
|
$404,274
0.08% of portfolio
|
Q3 2024
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 09, 2024 Q2 2024 |
53,227
shares
|
$388,557
0.0% of portfolio
|
Q2 2024
Reduced 60.43%
|
|
Northern Trust Corp
Chicago, IL |
Aug 14, 2024 Q2 2024 |
49,827
shares
|
$363,737
0.0% of portfolio
|
Q2 2024
Reduced 19.76%
|
|
Forbes J M & CO LLP
|
Oct 24, 2024 Q3 2024 |
48,401
shares
|
$353,327
0.03% of portfolio
|
Q3 2024
Added 2.07%
|
|
Gsa Capital Partners LLP
London, X0 |
Aug 15, 2024 Q2 2024 |
48,339
shares
|
$352,874
0.02% of portfolio
|
Q2 2024
Added 23.06%
|
|
Marshall Wace, LLP
London, X0 |
Aug 14, 2024 Q2 2024 |
33,868
shares
|
$247,236
0.0% of portfolio
|
Q2 2024
Reduced 32.36%
|
|
Y Intercept (Hong Kong) LTD
|
Aug 14, 2024 Q2 2024 |
23,173
shares
|
$169,162
0.01% of portfolio
|
Q2 2024
New holding
|
|
Edmond De Rothschild Holding S.A.
Chambesy, V8 |
Aug 13, 2024 Q2 2024 |
19,170
shares
|
$139,941
0.0% of portfolio
|
Q4 2023
New holding
|
|
Jane Street Group, LLC
New York, NY |
Aug 14, 2024 Q2 2024 |
17,021
shares
|
$124,253
0.0% of portfolio
|
Q2 2024
New holding
|
|
State Street Corp
Boston, MA |
Aug 14, 2024 Q2 2024 |
15,300
shares
|
$111,690
0.0% of portfolio
|
Q2 2024
Reduced 88.17%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2024 Q2 2024 |
14,937
shares
|
$109,040
0.0% of portfolio
|
Q2 2024
New holding
|
|
Jpmorgan Chase & CO
New York, NY |
Aug 12, 2024 Q2 2024 |
14,753
shares
|
$107,696
0.0% of portfolio
|
Q2 2024
Added 185.63%
|
|
Hrt Financial LP
New York, NY |
Aug 12, 2024 Q2 2024 |
13,627
shares
|
$99,477
0.0% of portfolio
|
Q2 2024
New holding
|
|
Centiva Capital, LP
New York, NY |
Aug 14, 2024 Q2 2024 |
13,300
shares
|
$97,090
0.0% of portfolio
|
Q2 2024
New holding
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2024 Q2 2024 |
13,044
shares
|
$95,221
0.0% of portfolio
|
Q2 2024
New holding
|
|
Baxter Bros Inc
|
Oct 29, 2024 Q3 2024 |
12,500
shares
|
$91,250
0.01% of portfolio
|
Q2 2024
New holding
|
|
Morgan Stanley
New York, NY |
Oct 17, 2024 Q2 2024 |
10,198
shares
|
$74,445
0.0% of portfolio
|
Q2 2024
Reduced 75.24%
|
|
Point72 Asia (Singapore) Pte. Ltd.
Singapore, U0 |
Aug 14, 2024 Q2 2024 |
9,203
shares
|
$67,181
0.01% of portfolio
|
Q2 2024
New holding
|